Cita APA

VanderVeen, N., Paran, C., Krasinkiewicz, J., Zhao, L., Palmer, D., Hervey-Jumper, S., . . . Castro, M. G. (2013). Effectiveness and Preclinical Safety Profile of Doxycycline to Be Used “Off-Label” to Induce Therapeutic Transgene Expression in a Phase I Clinical Trial for Glioma. Mary Ann Liebert, Inc.

Citación estilo Chicago

VanderVeen, Nathan, Christopher Paran, Jonathan Krasinkiewicz, Lili Zhao, Donna Palmer, Shawn Hervey-Jumper, Philip Ng, Pedro R. Lowenstein, y Maria G. Castro. Effectiveness and Preclinical Safety Profile of Doxycycline to Be Used “Off-Label” to Induce Therapeutic Transgene Expression in a Phase I Clinical Trial for Glioma. Mary Ann Liebert, Inc, 2013.

Cita MLA

VanderVeen, Nathan, et al. Effectiveness and Preclinical Safety Profile of Doxycycline to Be Used “Off-Label” to Induce Therapeutic Transgene Expression in a Phase I Clinical Trial for Glioma. Mary Ann Liebert, Inc, 2013.